Mechanism studies have shown that CX3CL1 exerts its anti‐HCC effect by signaling CX3CR1+ natural killer (NK) cell chemotaxis and cytotoxicity via transcription activation factor 3 (STAT). The gene discussed is CX3CR1; the disease is hepatocellular carcinoma.